Category
Tafamidis
CAS Number
594839-88-0
Molecular Formula
C₁₄H₇Cl₂NO₃
Molecular Weight
308.11 g/mol
Synonym

2-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic Acid; 2-(3,5-Dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid; Vyndamax

Keywords
Pharmaceutical Standards
Metabolites.
Impurities
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Tafamidis is a disease-modifying drug used for transthyretin amyloidosis (ATTR), a condition caused by misfolding of the transthyretin protein. It works by stabilizing the TTR protein and preventing it from forming harmful amyloid deposits. This action helps slow the progression of damage to the heart and nerves. It is used in both hereditary and cardiac forms of ATTR.